Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M95,181Revenue $M9,703Net Margin (%)32.4Altman Z-Score18.9
Enterprise Value $M93,535EPS $12.4Operating Margin %43.5Piotroski F-Score9
P/E(ttm)29.2Beneish M-Score-2.3Pre-tax Margin (%)43.3Higher ROA y-yY
Price/Book8.210-y EBITDA Growth Rate %26.5Quick Ratio2.3Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %25.5Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow29.6y-y EBITDA Growth Rate %54.9ROA % (ttm)24.0Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)31.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M235ROIC % (ttm)36.0Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 404.633%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 404.633%Sold Out0
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 404.633%Reduce 0.06%4,932
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 404.633%Add 2.28%81,058
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 404.6325%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 404.6325%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 404.6325%Reduce 84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 404.6323%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 404.6323%Reduce 58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 404.6323%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 404.6335%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 404.6335%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 404.6334%Reduce 6.62%559,700
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 404.6335%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 404.6335%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 404.6335%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 404.6334%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 404.6328%New holding116,000
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 404.6328%Reduce 32.19%599,400
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 404.6328%New holding7,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Posner Brian SDirector 2015-06-22Sell470$415-2.58view
WILLIAMS DOUGLAS EEVP Research & Development 2015-06-19Sell3,841$410-1.4view
Posner Brian SDirector 2015-06-15Sell400$386.644.56view
SCANGOS GEORGE ACEO 2015-06-01Sell1,362$398.871.36view
SCANGOS GEORGE ACEO 2015-05-01Sell1,362$377.527.09view
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-4.47view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-6.01view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-9.97view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-14.89view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-7.3view

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 
8 Top Healthcare Stocks to Watch May 13 2015 
Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
Vanguard Healthcare Fund Adds Four New Positions May 01 2015 
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma Apr 22 2015 
Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 

More From Other Websites
Healthcare Stocks Likely to Outperform despite Rate Hike Jul 06 2015
Biogen Collaboration With Applied Genetic Is 'Interesting,' But Morgan Stanley Will Wait For More... Jul 06 2015
Applied Genetic Up on Biogen Deal for Eye Disease Drugs - Analyst Blog Jul 03 2015
What You May Have Missed In Biotech: Celgene's $1B Bet On Cancer Immunotherapy, And A New CF Drug Jul 03 2015
Xoom Zooms, Teladoc Sinks a Day After Debut -- Tech Winners and Losers Jul 02 2015
Biogen: Where Did That Come From? Jul 02 2015
Applied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Deal Jul 02 2015
Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments Jul 02 2015
Biogen, AGTC Link Up To Develop Gene Therapy Jul 02 2015
Biogen deal pushes tiny company’s stock up by double digits Jul 02 2015
Biogen enters eye-treatment arena with AGTC deal Jul 02 2015
Biogen Opens Gene Therapy Partnership Worth About $1 Billion Jul 02 2015
Biogen And AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration Jul 02 2015
AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration Jul 02 2015
Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn... Jul 01 2015
U.S. doctors, hospitals reap $6.5 bln from drug and device makers -report Jun 30 2015
Why is Celgene So Darn Expensive? Jun 30 2015
Why Alexion Stock Could Rip Jun 30 2015
Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog Jun 29 2015
​Four ways that Biogen is being a good corporate citizen Jun 29 2015
Biogen and Sobi announce European Medicines Agency validates Alprolix® (rFIXFc) marketing... Jun 26 2015
Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX® (rFIXFc) Marketing... Jun 26 2015
US STOCKS-Dow, S&P 500 inch higher with financial, energy shares Jun 09 2015
Biogen 2015 Annual Shareholder Meeting Webcast May 28 2015
Biogen Names Matt Griffiths as Chief Information Officer May 13 2015
Biogen Announces $5 Billion Share Repurchase Program May 07 2015
Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell May 07 2015
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment... Apr 29 2015
US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
Biogen Reports First Quarter 2015 Revenues of $2.6 Billion Apr 24 2015
Biogen misses Street 1Q forecasts Apr 24 2015
FDA approves generic version of top-selling MS drug Copaxone Apr 17 2015
U.S. prescription drug spending rose 13 pct in 2014-IMS report Apr 13 2015
US stocks lifted by Shell, pharma deal news Apr 08 2015
US STOCKS-Wall Street down for 2nd straight day; energy weak Mar 24 2015
US STOCKS-Wall St drifts lower; Google buoys Nasdaq Mar 24 2015
Exclusive - Biogen shortens name, expands ambitions in Alzheimer's, ALS Mar 23 2015
Biogen shares soar on optimistic Alzheimer's drug study data Mar 20 2015
Biogen releases Alzheimer's drug data Mar 20 2015
Biogen Idec Presents Positive Interim Results from Phase 1B Study of Investigational Alzheimer’s... Mar 20 2015
GLOBAL MARKETS-U.S. stocks slip, dollar gains day after Fed view Mar 19 2015
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX®... Feb 27 2015
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug... Feb 05 2015
Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA... Feb 02 2015
Biogen tops 4Q profit forecasts Jan 29 2015
Biogen Idec 2014 Revenues Increase 40% to $9.7 Billion Jan 29 2015
Biogen Idec 2014 Revenues Increase 40% to $9.7 Billion Jan 29 2015
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Announce Global Collaboration to Develop... Jan 29 2015
CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on... Jan 26 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Insight - Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Saniona Announces Achievement of Milestone in Ataxia Program Jan 13 2015
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals Jan 11 2015
Biogen to buy private U.K. company with chronic pain drug Jan 11 2015
US STOCKS-Wall St set to climb for second day after claims data Jan 08 2015
US STOCKS-Dow ends above 18k for first time on strong GDP report Dec 23 2014
US STOCKS-GDP lifts Dow over 18k; biotechs have worst day since April Dec 23 2014
US STOCKS-Energy shares lead Wall St higher; telecoms slip Dec 02 2014
US STOCKS-Wall St inches lower with healthcare shares Nov 14 2014
US STOCKS-Futures inch up, indicating rebound; earnings awaited Oct 23 2014
Biogen beats Street 3Q forecasts Oct 22 2014
US STOCKS-Major indexes end down, but well off session lows Oct 15 2014
US STOCKS-Major indexes down more than 1 pct but off day's lows Oct 15 2014
US STOCKS-Wall St rallies, S&P back above 14-day moving average Sep 24 2014
FDA approves Biogen's MS drug Plegridy Aug 15 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK